A sample of the 26-year-old athlete’s urine contained “andarine,” “ostarine,” and “ligandrol,” as adverse analytical findings (AAF). The athlete is the defending national 100-meter champion and placed second at the 2018 Asian Games in both the 100-meter and 200-meter events. Indian sprinter Dutee Chand received a provisional suspension after testing positive for prohibited anabolic steroids outside of competition.
According to a doping control notification on adverse analytical findings issued by the National Anti-doping Agency (NADA), the urine sample of the 26-year-old athlete, who is the national 100-meter champion and finished second in both the 100-meter and 200-meter events at the 2018 Asian Games, returned adverse analytical findings (AAF) for “andarine,” “ostarine,” and “ligandrol.”
“I do hereby inform you that your sample A was tested at the NDTL (National Dope Testing Laboratory) in accordance with the procedure set out in WADA’s (World Anti-Doping Agency) International Standard of Laboratories and was returned adverse analytical findings as details given below,” the AAF notification stated in a letter addressed to Dutee.
On December 5 of the previous year, the sample was taken outside of the competition in Bhubaneswar. Additionally, the letter warned Dutee of the potential repercussions.
“I do hereby invite you to carefully read the contents of this letter, which provides important information as to the possible consequences of the AAF and the disciplinary process that results from it,” reads the remaining portion of the letter. I do ask that you read this letter carefully.
When asked about the positive result from the “A” sample, Dutee stated that she was unaware of it. “I’m not sure,” she said.
Read Also:- World Championship of Blitz: Indian Koneru Humpy wins the silver medal in the competition for women